Infections: News and Research on Respiratory Tract Infections

MeSH tree: C01.748

FDA approves Dupixent for allergic fungal rhinosinusitis

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis (AFRS) and a history of sino-nasal surgery.

Rethinking how to protect babies for longer against RSV

New strategies may be needed to protect infants older than six months against the highly infectious Respiratory Syncytial Virus or RSV, new University of Queensland research has found. The study examined 18,683 cases of RSV ...

page 8 from 40